Cite
Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS).
MLA
Cleland, John G. F., et al. “Measurement of Troponin and Natriuretic Peptides Shortly after Admission in Patients with Heart Failure-Does It Add Useful Prognostic Information? An Analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute Heart Failure Studies (VERITAS).” European Journal of Heart Failure, vol. 19, no. 6, June 2017, pp. 739–47. EBSCOhost, https://doi.org/10.1002/ejhf.786.
APA
Cleland, J. G. F., Teerlink, J. R., Davison, B. A., Shoaib, A., Metra, M., Senger, S., Milo, O., Cotter, G., Bourge, R. C., Parker, J. D., Jondeau, G., Krum, H., O’Connor, C. M., Torre-Amione, G., van Veldhuisen, D. J., McMurray, J. J. V., & VERITAS Investigators. (2017). Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS). European Journal of Heart Failure, 19(6), 739–747. https://doi.org/10.1002/ejhf.786
Chicago
Cleland, John G.F., John R. Teerlink, Beth A. Davison, Ahmad Shoaib, Marco Metra, Stefanie Senger, Olga Milo, et al. 2017. “Measurement of Troponin and Natriuretic Peptides Shortly after Admission in Patients with Heart Failure-Does It Add Useful Prognostic Information? An Analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute Heart Failure Studies (VERITAS).” European Journal of Heart Failure 19 (6): 739–47. doi:10.1002/ejhf.786.